Pulmonary embolism after dexamethasone treatment for COVID-19: a case report

被引:0
作者
Hidenori Takahashi
Yoshinobu Iwasaki
Takayasu Watanabe
Naoki Ichinose
Toshimi Oda
机构
[1] Showa General Hospital,Department of Pulmonary Medicine
[2] Showa General Hospital,Department of Infection Control
来源
BMC Infectious Diseases | / 22卷
关键词
COVID-19; SARS-CoV-2; Pulmonary embolism; Anticoagulation; Dexamethasone; Cytokine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 91 条
[1]  
Mecenas P(2020)Effects of temperature and humidity on the spread of COVID-19: a systematic review PLoS ONE 15 124-847
[2]  
Bastos RTDRM(2020)Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review Ann Intensive Care 10 834-2477
[3]  
Vallinoto ACR(2020)Late acute pulmonary embolism after mild coronavirus disease 2019 (COVID-19): a case series Rev Inst Med Trop Sao Paulo 62 2483-1723
[4]  
Normando D(2020)A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to neutrophil extracellular traps as mediators of thrombosis in COVID-19 medRxiv. 95 2465-192
[5]  
Sakr Y(2020)Hematological findings and complications of COVID-19 Am J Hematol 8 1711-1062
[6]  
Giovini M(2010)Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors J Thromb Haemost 133 190-1097
[7]  
Leone M(2019)Recommendations for the management of hemophagocytic lymphohistiocytosis in adults Blood 353 1054-15885
[8]  
Pizzilli G(2005)Anti-inflammatory action of glucocorticoids–new mechanisms for old drugs N Engl J Med 3 1089-undefined
[9]  
Kortgen A(2020)Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: a position paper from the National PERT Consortium Chest 395 141-undefined
[10]  
Bauer M(2020)A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan Glob Adv Health Med 30 15880-undefined